References
- Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development Goals. Lancet Child Adol Health [Internet]. 2022 Feb 1 [cited 2023 Jun 28];6:106–14. doi: 10.1016/S2352-4642(21)00311-4
- Decouttere C, De Boeck K, Vandaele N. Advancing sustainable development goals through immunization: a literature review. Glob Health [Internet]. 2021 Dec 1 [cited 2023 Jun 28];17. doi: 10.1186/s12992-021-00745-w
- United Nations. SDG indicators, metadata repository. [cited 2023 Mar 8]. Available from: https://unstats.un.org/sdgs/metadata/?Text=&Goal=3&Target=3.2
- United Nations. The sustainable development goals report 2022 [Internet]. New York, NY: United Nations Publications; 2022 [cited 2023 Mar 7]. 68. Available from: https://unstats.un.org/sdgs/report/2022/The-Sustainable-Development-Goals-Report2022.pdf
- Chen C, Cervero Liceras F, Flasche S, Sidharta S, Yoong J, Sundaram N, et al. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Glob Health [Internet]. 2019 Jan 1 [cited 2023 Jun 28];7:e58–67. doi: 10.1016/S2214-109X(18)30422-4
- Zakiyah N, Insani WN, Suwantika AA, van der Schans J, Postma MJ. Pneumococcal vaccination for children in Asian countries: a systematic review of economic evaluation studies. Vaccines [Internet]. 2020 Sep 1 [cited 2023 Jun 28];8:1–18. doi: 10.3390/vaccines8030426
- Toor J, Echeverria-Londono S, Li X, Abbas K, Carter ED, Clapham HE, et al. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife [Internet]. 2021 Jul 1 [cited 2023 Jun 28];10. doi: 10.7554/eLife.67635
- World Health Organization. Immunization Agenda 2030 [Internet]. [cited 2023 Jul 1]. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030
- World Health Organization. Pneumococcal vaccination coverage [Internet]. [cited 2023 Jul 1]. Available from: https://immunizationdata.who.int/pages/coverage/pcv.html?CODE=Global&ANTIGEN=&YEAR=
- Immunization Agenda 2030 Scorecard. Overview dashboard [Internet]. [cited 2023 Jun 28]. Available from: https://scorecard.immunizationagenda2030.org/
- World Health Organization. Introduction of PCV [Internet]. [cited 2023 Jul 1]. Available from: https://immunizationdata.who.int/pages/vaccine-intro-by-antigen/pneumo_conj.html
- Central Asia News. Tajikistan launches pneumococcal vaccination in children » Новости Центральной Азии [Internet]. 2022 Nov [cited 2023 Jun 30]. Available from: https://centralasia.news/17859-tajikistan-launches-pneumococcal-vaccination-in-children.html
- World Health Organization. The government guarantees PCV immunization for all Indonesian children to protect them from the dangers of pulmonary inflammation (pneumonia) [Internet]. 2022 Sept 12 [cited 2023 Jun 30]. Available from: https://www.who.int/indonesia/news/detail/12-09-2022-the-government-guarantees-pcv-immunization-for-all-indonesian-children-to-protect-them-from-the-dangers-of-pulmonary-inflammation-%28pneumonia%29
- TATOLI Agência Noticiosa de Timor-Leste Tatoli. Timor-Leste launches national integrated vaccination campaign – [Internet]. 2023 Jan 12 [cited 2023 Jun 30]. Available from: https://en.tatoli.tl/2023/01/12/timor-leste-launches-national-integrated-vaccination-campaign/17/
- Burchett HED, Mounier-Jack S, Griffiths UK, Mills AJ. National decision-making on adopting new vaccines: a systematic review. Health Policy Plann [Internet]. 2011 July 6 [cited 2023 Jun 30];27:ii62–76. doi: 10.1093/heapol/czr049.
- Shen AK, Fields R, McQuestion M. The future of routine immunization in the developing world: challenges and opportunities. Global Health [Internet]. 2014 Dec 2 [cited 2023 Jun 30];2:381. doi: 10.9745/GHSP-D-14-00137
- Gordon WS, Jones A, Wecker J. Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges. Health Policy Plan [Internet]. 2012 May [cited 2023 Jun 30];27:ii17–ii26. Available from: https://pubmed.ncbi.nlm.nih.gov/22513729/
- Privor-Dumm L, Vasudevan P, Kobayashi K, Gupta J. Archetype analysis of older adult immunization decision-making and implementation in 34 countries. Vaccine [Internet]. 2020 May 27 [cited 2023 Jun 30];38:4170–4182. doi: 10.1016/j.vaccine.2020.04.027
- The World Bank. World Bank country and lending groups [Internet]. [cited 2023 Jun 30]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
- World Health Organization. Immunization data [Internet]. [cited 2023 Jul 1]. Available from: https://immunizationdata.who.int/index.html
- Guillaume D, Meyer D, Waheed DEN, Schlieff M, Muralidharan K, Chou VB, et al. Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review. Health Policy Plann. 2023 Mar 16 [cited 2023 Jun 30];38:363–376. doi: 10.1093/heapol/czac092
- World Health Organization. Vaccine supply and logistics [Internet]. [cited 2023 Sep 20]. Available from: https://immunizationdata.who.int/pages/indicators-by-category/vaccine_supply.html?ISO_3_CODE=&YEAR=
- Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of streptococcus pneumoniae and haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health [Internet]. 2018 Jul 1 [cited 2023 Jun 30]; 6:e744–57. doi: 10.1016/S2214-109X(18)30247-X
- London School of Hygiene & Tropical Medicine. RESYST. A target for UHC: how much should governments spend on health? [Internet]. 2017 May [cited 2023 Jul 1]. Available from: https://resyst.lshtm.ac.uk/resources/a-target-for-uhc-how-much-should-governments-spend-on-health
- Open database: World Bank Open Data [Internet]. The World Bank; [cited 2023 Jul 1]. Available from: https://data.worldbank.org/
- Masresha BG, Luce R, Okeibunor J, Shibeshi ME, Kamadjeu R, Fall A. Introduction of the second dose of measles containing vaccine in the childhood vaccination programs within the WHO Africa region – lessons learnt. J Immunol Sci. 2018 Jul 28 [cited 2023 Jul 1];2:113–121. doi: 10.29245/2578-3009/2018/si.1117
- Sambala EZ, Wiyeh AB, Ngcobo N, Machingaidze S, Wiysonge CS. New vaccine introductions in Africa before and during the decade of vaccines – are we making progress? Vaccine [Internet]. 2019 May 31 [cited 2023 Jun 30];37:3290–3295. doi: 10.1016/j.vaccine.2019.05.002
- World Health Organization. Accelerating introduction of new vaccines and related technologies [Internet]. [cited 2023 Jul 1]. Available from: https://www.who.int/southeastasia/activities/accelerating-introduction-of-new-vaccines-and-related-technologies
- Howard N, Walls H, Bell S, Mounier-Jack S. The role of national immunisation technical advisory groups (NITAGs) in strengthening national vaccine decision-making: a comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda. Vaccine [Internet]. 2018 Sep 9 [cited 2023 Jun 30];36:5536. doi: 10.1016/j.vaccine.2018.07.063
- Duclos P, Ortynsky S, Abeysinghe N, Cakmak N, Janusz CB, Jauregui B, et al. Monitoring of progress in the establishment and strengthening of national immunization technical advisory groups. Vaccine [Internet]. 2012 Nov 26 [cited 2023 Jun 30]; 30:7147–7152. doi: 10.1016/j.vaccine.2012.04.015
- Blau J, Sadr-Azodi N, Clementz M, Abeysinghe N, Cakmak N, Duclos P, et al. Indicators to assess national immunization technical advisory groups (NITAGs). Vaccine [Internet]. 2013 May 28 [cited 2023 Jun 30];31:2653–2657. doi: 10.1016/j.vaccine.2013.01.047
- Wiyeh AB, Sambala EZ, Ngcobo N, Wiysonge CS. Existence and functionality of national immunization technical advisory groups in Africa from 2010 to 2016. Hum Vaccines Immunother [Internet]. 2018 Oct 3 [cited 2023 Jun 30];14:2447. doi: 10.1080/21645515.2018.1475815
- World Health Organization. Guidelines on interagency coordinating committees [Internet]. 2022 June [cited 2023 Jun 30]. Available from: https://www.afro.who.int/publications/guidelines-interagency-coordinating-committees
- Gavi, The Vaccine Alliance. Gavi’s approach to engaging with middle-income countries [Internet]. 2023 Mar 13 [cited 2023 Jun 30]. Available from: https://www.gavi.org/types-support/sustainability/gavi-mics-approach
- Gavi, The Vaccine Alliance. Fragility, emergencies and displaced populations policy [Internet]. 2022 Jun 28 [cited 2023 Jun 30]. Available from: https://www.gavi.org/programmes-impact/programmatic-policies/fragility-emergencies-and-displaced-populations-policy
- The World Bank. The World Bank in Ukraine [Internet]. [cited 2023 Jul 1]. Available from: https://www.worldbank.org/en/country/ukraine/overview
- Pereira ADL, Southgate R, Ahmed H, O’Connor P, Cramond P, Lenglet A. Infectious disease risk and vaccination in Northern Syria after 5 years of civil war: the MSF experience. PLoS Curr [Internet]. 2018 Feb 2 [cited 2023 Sep 20];1. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815631/
- Grundy J, Biggs BA. The impact of conflict on immunization coverage in 16 countries. Int J Health Policy Manag [Internet]. 2019 Apr 8 [cited 2023 Sep 20];8:211–221. doi: 10.15171/ijhpm.2018.127
- Wenger JD, Difabio JL, Landaverde JM, Levine OS, Gaafar T. Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four “newly adopting” countries. Vaccine [Internet]. 1999 Nov 12 [cited 2023 Jun 30];18:736–742. doi: 10.1016/S0264-410X(99)00269-8
- Widdus R. Introduction of vaccines into the third world. Comptes Rendus l’Academie des Sci – Ser III [Internet]. 1999 Nov [cited 2023 Jun 30];322:999–1010. Available from: https://pubmed.ncbi.nlm.nih.gov/10646097/
- Miller MA, Flanders WD. A model to estimate the probability of hepatitis B- and Haemophilus influenzae type b-vaccine uptake into national vaccination programs. Vaccine [Internet]. 2000 Apr [cited 2023 Jun 30];18:2223–2230. doi: 10.1016/S0264-410X(99)00563-0
- Shearer JC, Stack ML, Richmond MR, Bear AP, Hajjeh RA, Bishai DM. Accelerating policy decisions to adopt haemophilus influenzae type b vaccine: a global, multivariable analysis. PLOS Med [Internet]. 2010 Mar 16 [cited 2023 Jun 30];7:e1000249. doi: 10.1371/journal.pmed.1000249.
- Saokaew S, Rayanakorn A, Wu DBC, Chaiyakunapruk N. Cost effectiveness of pneumococcal vaccination in children in low- and middle-income countries: a systematic review. PharmacoEconomics [Internet]. 2016 Dec 1 [cited 2023 Jun 30];34:1211–1225. doi: 10.1007/s40273-016-0439-3.
- Centers for Disease Control and Prevention. CDC vaccine price list [Internet]. 2023 Sep 15 [cited 2023 Sep 20]. Available from: https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html
- Pan American Health Organization. PAHO revolving fund vaccine prices for 2023 [Internet]. 2023 Jan 20 [cited 2023 Jun 30]. Available from: https://www.paho.org/en/documents/paho-revolving-fund-vaccine-prices-2023
- UNICEF. Pneumococcal conjugate vaccine (PCV) price data [Internet]. [cited 2023 Jun 30]. Available from: https://www.unicef.org/supply/documents/pneumococcal-conjugate-vaccine-pcv-price-data
- Levine OS, Cherian T, Shah R, Batson A. PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries [Internet]. 2004 Sep [cited 2023 Jun 30];22:268–274. Available from: https://pubmed.ncbi.nlm.nih.gov/15609779/#:~:text=The%20Pneumococcal%20Vaccines%20Accelerated%20Development,pneumococcal%20vaccines%20for%20developing%20countries
- Gavi, the Vaccine Alliance. Advance market commitment for pneumococcal vaccines. Annual Report 1 January-31 December 2020 [Internet]. Available from: https://www.gavi.org/sites/default/files/document/2021/2020-PCV-AMC-Annual-Report.pdf
- Gavi, the Vaccine Alliance. Product information for vaccines and cold chain equipment [Internet]. 2023 Jun 14 [cited 2023 Jul 1]. Available from: https://www.gavi.org/our-alliance/market-shaping/product-information-vaccines-cold-chain-equipment
- Tricarico S, McNeil HC, Cleary DW, Head MG, Lim V, Yap IKS, et al. neumococcal conjugate vaccine implementation in middle-income countries. Pneumonia [Internet]. 2017 Mar 25 [cited 2023 Jul 1];9. Available from: https://pubmed.ncbi.nlm.nih.gov/28702308/
- Berkley S. Vaccination lags behind in middle-income countries. Nature [Internet]. 2019 May [cited 2023 Jul 1];569:309. doi: 10.1038/d41586-019-01494-y
- Kaddar M, Schmitt S, Makinen M, Milstien J. Global support for new vaccine implementation in middle-income countries. Vaccine [Internet]. 2013 Apr 18 [cited 2023 Jul 1];31:B81–96. doi: 10.1016/j.vaccine.2012.11.085
- International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. Introducing the pneumococcal conjugate vaccine (PCV) in Jordan [Internet]. 2023 Jan 15 [cited 2023 Jul 1]. Available from: https://www.jhsph.edu/ivac/wp-content/uploads/2022/05/Introducing-the-PCV-in-Jordan-Jan-2023_final.pdf
- Every Breath Counts, International vaccine access center, Save the children. Enabling the introduction of lifesaving pneumonia vaccines for children in fragile settings. Joint Statement. 2023 Mar 9 [cited 2023 Jul 1]. Available from: https://stoppneumonia.org/wp-content/uploads/2023/03/JointStatementPCVFragileCountriesEBC-IVAC-Save-the-Children-March-2023.pdf
- The World Bank. The World Bank in Sri Lanka [Internet]. 2022 Oct 6 [cited 2023 Jul 1]. Available from: https://www.worldbank.org/en/country/srilanka/overview
- Madhi SA, Nunes MC. The potential impact of pneumococcal conjugate vaccine in Africa: considerations and early lessons learned from the South African experience. Hum Vaccines Immunother [Internet]. 2016 [cited 2023 Jul 1];12:314. doi: 10.1080/21645515.2015.1084450.
- Rurangwa J, Rujeni N. Decline in child hospitalization and mortality after the introduction of the 7-valent pneumococcal conjugative vaccine in Rwanda. Am J Trop Med Hyg [Internet]. 2016 Sep 7 [cited 2023 Jul 1];95:680. doi: 10.4269/ajtmh.15-0923
- Mackenzie GA, Hill PC, Jeffries DJ, Ndiaye M, Sahito SM, Hossain I, et al. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in the Gambia: 10 years of population-based surveillance. Lancet Infect Dis [Internet]. 2021 Sep [cited 2023 Jul 1];21:1293–1302. doi: 10.1016/S1473-3099(20)30880-X
- Hammitt LL, Etyang AO, Morpeth SC, Ojal J, Mutuku A, Mturi N, et al. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study. Lancet [Internet]. 2019 May 25 [cited 2023 Jul 1]; 393:2146. doi: 10.1016/S0140-6736(18)33005-8
- Mpabalwani EM, Lukwesa-Musyani C, Imamba A, Nakazwe R, Matapo B, Muzongwe CM, et al. Declines in pneumonia and meningitis hospitalizations in children under 5 years of age after introduction of 10-valent pneumococcal conjugate vaccine in Zambia, 2010-2016. Clinl Infect Dis [Internet]. 2019 Sep 1 [cited 2023 Jul 1];69:S58–65. Available from: https://europepmc.org/articles/PMC6761309.
- Kaboré L, Ouattara S, Sawadogo F, Gervaix A, Galetto-Lacour A, Karama R, et al. Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: an interrupted time-series analysis. Inter J Infect Dis [Internet]. 2020 Jul 1 [cited 2023 Jul 1]; 96:31–38. doi: 10.1016/j.ijid.2020.03.051
- Every breath counts: introducing the pneumococcal conjugate vaccine (PCV) in Somalia, Guinea, South Sudan, and Chad [Internet]. 2022 Feb 3. Available from: https://stoppneumonia.org/wp-content/uploads/2022/02/EveryBreathCountsIntroducingPCVReport-1.pdf
- García Fariñas A, Linares-Pérez N, Clark A, Toledo-Romaní ME, El Omeiri N, Marrero Araújo MC, et al. Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme. Inter J Infect Dis [Internet]. 2020 Aug 1 [cited 2023 Jul 1];97:182–189. doi: 10.1016/j.ijid.2020.05.078
- Yimin M. First China-made 13-valent pneumonia vaccine to hit the market. CGTN [Internet]. 2020 Jan 2 [cited 2023 Mar 8]. Available from: https://news.cgtn.com/news/2020-01-02/First-China-made-13-valent-pneumonia-vaccine-to-hit-the-market-MVR3v4QTle/index.html
- Gavi, the Vaccine Alliance. Pneumococcal vaccine support [Internet]. 2023 Aug 22 [cited 2023 Sep 20]. Available from: https://www.gavi.org/types-support/vaccine-support/pneumococcal
- De Oliveira LH, Trumbo SP, Matus CR, Sanwogou NJ, Toscano CM. Pnuemococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned. Expert Rev Vaccines [Internet]. 2016 Oct [cited 2023 Sep 20];15:1295–1304. Available from: https://pubmed.ncbi.nlm.nih.gov/26982434/
- JSI, Gavi, the Vaccine Alliance. Lessons learned: rotavirus & PCV vaccine introduction in Niger [Internet]. 2016 Mar. Available from: https://www.jsi.com/resource/lessons-learned-rotavirus-pcv-vaccine-introduction-in-niger/
- Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines [Internet]. 2021 Feb 16 [cited 2023 Jul 1];9:1–15. doi: 10.3390/vaccines9020160
- Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccine Immunother [Internet]. 2013 Aug [cited 2023 Jul 1];9:1763–1773. doi: 10.4161/hv.24657
- MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine Hesitancy: definition, scope and determinants. Vaccine [Internet]. 2015 Aug 14 [cited 2023 Jul 1];33:4161–4164. doi: 10.1016/j.vaccine.2015.04.036
- UNICEF. The state of the World’s children 2023 [Internet]. 2023 Apr [cited 2023 Jul 1]. Available from: https://www.unicef.org/reports/state-worlds-children-2023